Evidence map›Paper›PMID 36384313›Full record

ArticleJournal of diabetes science and technology2024

Improving Care for People Living With Dementia and Diabetes: Applying the Human-Centered Design Process to Continuous Glucose Monitoring.

April Savoy, Richard J Holden, Mary de Groot, Daniel O Clark, Greg A Sachs, David Klonoff, Michael Weiner

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Observational
  6. Clin-STAR Corner: Practice Changing Advances in Diabetes Care.Journal of the American Geriatrics Society · 2025
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

April SavoyPurdue School of Engineering & Technology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA.ORCID 0000-0001-9002-9234
Richard J HoldenRegenstrief Institute, Inc., Indianapolis, IN, USA.
Mary de GrootIndiana University School of Medicine, Indianapolis, IN, USA.
Daniel O ClarkRegenstrief Institute, Inc., Indianapolis, IN, USA.
Greg A SachsRegenstrief Institute, Inc., Indianapolis, IN, USA.
David KlonoffSchool of Medicine, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0001-6394-6862
Michael WeinerRegenstrief Institute, Inc., Indianapolis, IN, USA.
Regenstrief Institute · USIndiana University School of MedicineUniversity of California, San Francisco · US

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Translating Measures of Visual Experience to Children with Autism and Down SyndromeKL2TR002530 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI ROBB, SHERI L · 2018 to 2022
$4.8M
Enhancing shared decision-making to prompt and guide individualized care for people with Alzheimer's Disease and DiabetesK01AG076971 · NIA · PURDUE UNIVERSITY · PI April Savoy · 2022 to 2026
$634k
NCATS NIH HHS KL2 TR002530NCATS NIH HHS UL1 TR002529NIA NIH HHS K01 AG076971
6 · The paper itself

Abstract

People with Alzheimer's disease or related dementias and diabetes mellitus (ADRD-DM) are at high risk for hypoglycemic events. Their cognitive impairment and psychosocial situation often hinder detection of hypoglycemia. Extending use and benefits of continuous glucose monitoring (CGM) to people with ADRD-DM could improve hypoglycemia detection, inform care, and reduce adverse events. However, cognitive impairment associated with ADRD presents unique challenges for CGM use. This commentary proposes applying the human-centered design process to CGM, investigating design solutions or interventions needed to integrate CGM into the health care of patients with ADRD-DM. With this process, we can identify and inform CGM designs for people with ADRD-DM, broadening CGM access, increasing detection and treatment of the silent threat posed by hypoglycemia.

Indexed as

DementiaDiabetes Mellitus, Type 1HypoglycemiaBlood GlucoseBlood Glucose Self-MonitoringContinuous Glucose MonitoringHumansHypoglycemic AgentsQuality ImprovementBlood GlucoseHypoglycemic Agentscontinuous glucose monitoringdementiadiabeteshuman factorsprimary care

Identifiers

PMID36384313
PMCPMC10899847
OpenAlexW4309242904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.